Bank of America’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
LJAC
IAIM
CS
JAWM
IAN
KA
Bank of America's FTXH Position: Q2 2021 in Review
Bank of America sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2021, closing a stake of 1,329 shares — an estimated $34K sold.
Bank of America first reported a position in FTXH in Q3 2017 and held it in 15 quarters. The position peaked at $131K in Q2 2020. 18 funds tracked by Wall St. Rank hold FTXH as of Q2 2021.
- Bank of America reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
- Bank of America sold 1,329 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2021, an estimated $34K.
- Bank of America first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2017 and held it in 15 quarters.
- Bank of America's First Trust Nasdaq Pharmaceuticals ETF position peaked at $131K in Q2 2020.
- 18 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2021.
Based on Bank of America's 13F filing for Q2 2021, filed 16 Aug 2021.